Michael Tomsicek
Fortuna: 36 773 $ al 30/06/2026
Fortuna: 36 773 $ al 30/06/2026
El Sr. Michael J. Tomsicek es director independiente no ejecutivo de Milestone Pharmaceuticals, Inc. y director financiero y contable principal de CRISPR Therapeutics AG. Forma parte del Consejo de Administración de Milestone Pharmaceuticals, Inc. y de Optimer Pharmaceuticals LLC. Anteriormente, el Sr. Tomsicek fue director financiero, tesorero, contable principal y vicepresidente de ABIOMED, Inc., tesorero de Cubist Pharmaceuticals, Inc., director financiero del grupo de productos de ultrasonido global de General Electric Healthcare Technologies, Inc. y director de finanzas comerciales y planificación empresarial de Motorola Automotive & Industrial Electronics Group, así como director financiero de The Lexington. También formó parte del consejo de administración de Trius Therapeutics, Inc. Se licenció en la Universidad de Wisconsin y obtuvo un MBA en la Universidad de Wisconsin.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 10/06/2026 | 15.001 ( 0,01 % ) | 20 101 $ | 30/06/2026 | |
| 17/06/2026 | 9.366 ( 0,02 % ) | 16 671 $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| MILESTONE PHARMACEUTICALS INC. | Director/Miembro de la Junta | 01/04/2019 |
| ACRIVON THERAPEUTICS, INC. | Director/Miembro de la Junta | 01/10/2022 |
Optimer Pharmaceuticals LLC
Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes anti-infective products | Director/Miembro de la Junta | 24/10/2013 |
Cimeio Therapeutics AG
Cimeio Therapeutics AG BiotechnologyHealth Technology Operates as a biotechnology company developing shielded-cell & immunotherapy pairs, which protect genetically modified cells from targeted therapies | Director/Miembro de la Junta | 03/11/2022 |
| Empresas | Cargo | Fin |
|---|---|---|
| CRISPR THERAPEUTICS AG | Director Financiero/CFO | 14/10/2021 |
| ABIOMED, INC. | Director Financiero/CFO | 24/08/2017 |
| CUBIST PHARMACEUTICALS INC | Director Financiero/CFO | 01/01/2015 |
General Electric Healthcare Technologies, Inc.
General Electric Healthcare Technologies, Inc. Medical/Nursing ServicesHealth Services Provides transformational medical technologies and services | Corporate Officer/Principal | 01/09/2010 |
The Lexington
The Lexington Medical/Nursing ServicesHealth Services Operates a 125-bed assisted living facility | Director Financiero/CFO | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 12 |
|---|---|
ABIOMED, Inc.
ABIOMED, Inc. Medical SpecialtiesHealth Technology Manufactures cardiac support, recovery and replacement devices | Health Technology |
Cubist Pharmaceuticals LLC
Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Engages in research, development and commercialization of pharmaceutical products | Health Technology |
Milestone Pharmaceuticals, Inc.
Milestone Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures cardiovascular medicines | Health Technology |
University of Wisconsin
University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Optimer Pharmaceuticals LLC
Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes anti-infective products | Health Technology |
Trius Therapeutics, Inc.
Trius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops antibacterial drugs for the treatment of infections | Health Technology |
General Electric Healthcare Technologies, Inc.
General Electric Healthcare Technologies, Inc. Medical/Nursing ServicesHealth Services Provides transformational medical technologies and services | Health Services |
The Lexington
The Lexington Medical/Nursing ServicesHealth Services Operates a 125-bed assisted living facility | Health Services |
Motorola Automotive & Industrial Electronics Group | |
CRISPR Therapeutics AG
CRISPR Therapeutics AG BiotechnologyHealth Technology Develops gene-based medicines | Health Technology |
Acrivon Therapeutics, Inc.
Acrivon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops and sells precision oncology medicines | Health Technology |
Cimeio Therapeutics AG
Cimeio Therapeutics AG BiotechnologyHealth Technology Operates as a biotechnology company developing shielded-cell & immunotherapy pairs, which protect genetically modified cells from targeted therapies | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.